BioRestorative Therapies
BRTX
11 hedge funds and large institutions have $184K invested in BioRestorative Therapies in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.
1.03% less ownership
Funds ownership: 3.69% → 2.66% (-1%)
15% less funds holding
Funds holding: 13 → 11 (-2)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
52% less capital invested
Capital invested by funds: $383K → $184K (-$199K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$134K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$106K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$64.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$229 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$51 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$54.8K |
| 2 |
NF
Napier Financial
Braintree,
Massachusetts
|
-$20.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$13.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$71 |
BRTX Hedge Fund Activity: Q1 2026 in Review
11 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q1 2026, worth a combined $184K — down 52% from $383K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BRTX and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, adding an estimated $134K. The largest seller was DRW Securities, exiting entirely with an estimated $54.8K sold.
- 11 institutional investors held BioRestorative Therapies (BRTX) as of Q1 2026, down from 13 in Q4 2025.
- Funds reported $184K of BioRestorative Therapies stock for Q1 2026, down 52% quarter-over-quarter.
- 3 funds opened new BioRestorative Therapies positions in Q1 2026 and 4 closed out, a net change of -1 holder.
- The largest BioRestorative Therapies buyer in Q1 2026 was Citadel Advisors, an estimated $134K added.
- The largest BioRestorative Therapies seller in Q1 2026 was DRW Securities, an estimated $54.8K sold.
Based on aggregated 13F filings for Q1 2026.